Martek Biosciences Corp. (Columbia, MD) is restructuring its Winchester, KY, facility to improve capacity and reduce manufacturing and operating costs.
Martek Biosciences Corp. (Columbia, MD) is restructuring its Winchester, KY, facility to improve capacity and reduce manufacturing and operating costs. The company will also reduce its workforce and transfer certain manufacturing and distribution processes to the company’s Kingstree, SC, site. The company says it is looking to offset price reductions stemming from the company’s current infant-formula contracts, such as with Mead Johnson.
Regarding Mead Johnson, Martek has extended its sole-supplier agreement with the company for docosahexaenoic acid (DHA) and arachidonic acid (ARA). Under the agreement, Martek will remain Mead Johnson’s sole supplier of DHA and ARA for all Mead Johnson infant-formula products through December 2015.
Roquette completes acquisition of IFF Pharma Solutions
May 1st 2025The integration of IFF Pharma Solution’s expertise and innovative product portfolio enhances Roquette’s “ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide while reinforcing its commitment to innovation,” according to the company’s press release.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.